StockData
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. (CTXR) stock

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.51−0.01 (-1.56%)

Close on Nov 18, 2026Market cap $14.02MP/E –Yield –

Citius Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Citius Pharmaceuticals's revenue for the twelve months ending Sep 30, 2022 was $90.00K, up 0.0% year over year. For fiscal 2022 it was $90.00K, up 0.0% from the year before. The highest annual figure on record is $90.00K in fiscal 2019.

Annual revenue

PeriodPeriod endValueChange
FY2022Sep 30, 2022$90.00K0.0%
FY2021Sep 30, 2021$90.00K0.0%
FY2020Sep 30, 2020$90.00K0.0%
FY2019Sep 30, 2019$90.00K+20.0%
FY2018Sep 30, 2018$75.00K+50.0%
FY2017Sep 30, 2017$50.00K–
FY2012Sep 30, 2012$0–
FY2011Sep 30, 2011$0–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$1.49M–
Q2 FY2026CQ1 2026Mar 31, 2026$1.67M–
Q1 FY2026CQ4 2025Dec 31, 2025$3.94M–
Q4 FY2022CQ3 2022Sep 30, 2022$0–
Q4 FY2021CQ3 2021Sep 30, 2021$0–
Q4 FY2020CQ3 2020Sep 30, 2020$0–
Q4 FY2019CQ3 2019Sep 30, 2019$0–
Q4 FY2018CQ3 2018Sep 30, 2018$0–

More Citius Pharmaceuticals figures

See a number that looks wrong?